132 related articles for article (PubMed ID: 8793910)
1. Effects of N-methyl-D-aspartate receptor antagonists on cisplatin-induced emesis in the ferret.
Lehmann A; Kärrberg L
Neuropharmacology; 1996 Apr; 35(4):475-81. PubMed ID: 8793910
[TBL] [Abstract][Full Text] [Related]
2. Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice.
Popik P; Kozela E; Danysz W
Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):425-32. PubMed ID: 10763858
[TBL] [Abstract][Full Text] [Related]
3. Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered excitatory amino acid receptor antagonists.
Hao JX; Xu XJ
Pain; 1996 Aug; 66(2-3):279-85. PubMed ID: 8880851
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cisplatin-induced emesis in ferrets by the non-NMDA receptor antagonists NBQX and CNQX.
Fink-Jensen A; Judge ME; Hansen JB; Jacobsen P; Turski L; Olney J; Honoré T
Neurosci Lett; 1992 Mar; 137(2):173-7. PubMed ID: 1350077
[TBL] [Abstract][Full Text] [Related]
5. Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats.
Zakharova ES; Danysz W; Bespalov AY
Psychopharmacology (Berl); 2005 Apr; 179(1):128-35. PubMed ID: 15682308
[TBL] [Abstract][Full Text] [Related]
6. Effects of 5-HT3 receptor antagonists on models of acute and delayed emesis induced by cisplatin in the ferret.
Rudd JA; Naylor RJ
Neuropharmacology; 1994 Dec; 33(12):1607-8. PubMed ID: 7760983
[TBL] [Abstract][Full Text] [Related]
7. The antiemetic activity of granisetron against cytostatic-treatment-induced emesis in 10- to 13-week-old ferrets.
Marr HE; Davey PT; Boyle EA; Blower PR
J Cancer Res Clin Oncol; 1994; 120(4):204-7. PubMed ID: 8288674
[TBL] [Abstract][Full Text] [Related]
8. Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin.
Rudd JA; Ngan MP; Wai MK; King AG; Witherington J; Andrews PL; Sanger GJ
Neurosci Lett; 2006 Jan; 392(1-2):79-83. PubMed ID: 16182445
[TBL] [Abstract][Full Text] [Related]
9. DAT-582, a novel serotonin3 receptor antagonist, is a potent and long-lasting antiemetic agent in the ferret and dog.
Yoshida N; Omoya H; Ito T
J Pharmacol Exp Ther; 1992 Mar; 260(3):1159-65. PubMed ID: 1532032
[TBL] [Abstract][Full Text] [Related]
10. Further studies of the antiemetic activity of granisetron against whole body X-irradiation or cisplatin-induced emesis in the ferret.
Marr HE; Davey PT; Boyle EA; Blower PR
Pharmacology; 1994 May; 48(5):283-92. PubMed ID: 8016189
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice.
Kozela E; Pilc A; Popik P
Psychopharmacology (Berl); 2003 Jan; 165(3):245-51. PubMed ID: 12442203
[TBL] [Abstract][Full Text] [Related]
12. Ketamine, an N-methyl-D-aspartate receptor antagonist, inhibits the reflex responses to distension of the rat urinary bladder.
Castroman PJ; Ness TJ
Anesthesiology; 2002 Jun; 96(6):1401-9. PubMed ID: 12170053
[TBL] [Abstract][Full Text] [Related]
13. The effects of different antiemetic agents on morphine-induced emesis in ferrets.
Wynn RL; Essien E; Thut PD
Eur J Pharmacol; 1993 Sep; 241(1):47-54. PubMed ID: 8223924
[TBL] [Abstract][Full Text] [Related]
14. Low doses of dextromethorphan have a beneficial effect in the treatment of neuropathic pain.
Morel V; Pickering G; Etienne M; Dupuis A; Privat AM; Chalus M; Eschalier A; Daulhac L
Fundam Clin Pharmacol; 2014 Dec; 28(6):671-80. PubMed ID: 24702319
[TBL] [Abstract][Full Text] [Related]
15. The effects of orally administered Y-25130, a selective serotonin3-receptor antagonist, on chemotherapeutic agent-induced emesis.
Haga K; Inaba K; Shoji H; Morimoto Y; Fukuda T; Setoguchi M
Jpn J Pharmacol; 1993 Nov; 63(3):377-83. PubMed ID: 8107329
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin-induced emesis in the cat: effect of granisetron and dexamethasone.
Rudd JA; Tse JY; Wai MK
Eur J Pharmacol; 2000 Mar; 391(1-2):145-50. PubMed ID: 10720646
[TBL] [Abstract][Full Text] [Related]
17. Morphine 6-glucuronide: a metabolite of morphine with greater emetic potency than morphine in the ferret.
Thompson PI; Bingham S; Andrews PL; Patel N; Joel SP; Slevin ML
Br J Pharmacol; 1992 May; 106(1):3-8. PubMed ID: 1324067
[TBL] [Abstract][Full Text] [Related]
18. Effects of N-methyl-D-aspartate antagonists on different measures of motion sickness in cats.
Lucot JB
Brain Res Bull; 1998 Nov; 47(5):407-11. PubMed ID: 10052568
[TBL] [Abstract][Full Text] [Related]
19. Competitive NMDA receptor antagonists disrupt prepulse inhibition without reduction of startle amplitude in a dopamine receptor-independent manner in mice.
Furuya Y; Kagaya T; Ogura H; Nishizawa Y
Eur J Pharmacol; 1999 Jan; 364(2-3):133-40. PubMed ID: 9932715
[TBL] [Abstract][Full Text] [Related]
20. Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine.
Peeters M; Gunthorpe MJ; Strijbos PJ; Goldsmith P; Upton N; James MF
J Pharmacol Exp Ther; 2007 May; 321(2):564-72. PubMed ID: 17267580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
